Patients who developed late right heart failure (RHF) after left ventricular assist device (LVAD) surgery suffered more major adverse events and had worse survival, researchers found. At 1 month ...

North Shore University Hospital’s cardiology team became the first to complete a procedure using the novel OmniaSecure ...

This article originally appeared in the National Association of EMS Physicians blog and is reprinted here with permission. By ...

Events picked up with the Fourth Universal Definition of MI were tied to higher mortality, emphasizing the role of ancillary ...

NIMS, Hyderabad, successfully treated two young patients with ventricular premature contractions (VPCs) using advanced 3D ...

The patients were suffering from persistent ventricular premature contractions (VPCs), presenting as ventricular bigeminy — a condition in which nearly every alternate heartbeat is abnormal.

The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...

HIC built world-class cardiovascular care in Colombia by fusing together global standards, innovation and human-centered ...

Medtronic this week launched its OmniaSecure defibrillation lead in the U.S., describing it as the world's smallest.

The FDA-approved OmniaSecure defibrillation lead from Medtronic is a thin wire that connects an implantable cardioverter defibrillator to the heart.

A tiny leadless pacemaker implanted at Netcare Unitas Hospital marks a significant step in treating heart rhythm disorders.

Preliminary results from the FULCRUM-VT trial point to a safer, more effective way to treat ventricular tachycardia—a dangerous heart rhythm disorder that can lead to sudden cardiac arrest.